H U Group Holdings (TSE:4544) Notes Receivable: 円0 Mil (As of Mar. 2026)


TSE:4544 H U Group Holdings Inc TSE:4544
67 GF Score
Price 円3,470.00
GF Value 円2,774.67
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is H U Group Holdings Notes Receivable?

H U Group Holdings TSE:4544 +0.99% 67 Notes Receivable is 円0 Mil as of Mar. 2026. GuruFocus rates TSE:4544 with a GF Score™ of 67/100 and a GF Value™ of 円2,774.67 (Modestly Overvalued). The stock has 5 warning signs investors should review.

H U Group Holdings's Notes Receivable for the quarter that ended in Mar. 2026 was 円0 Mil.

H U Group Holdings Notes Receivable Related Terms

H U Group Holdings Notes Receivable Historical Data

* Premium members only.

The historical data trend for H U Group Holdings's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

H U Group Holdings Notes Receivable Chart

H U Group Holdings Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

H U Group Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:4544
67GF Score
H U Group Holdings Inc TSE:4544
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

H U Group Holdings Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of 円0 Mil mean?
H U Group Holdings (TSE:4544) has a Notes Receivable of 円0 Mil as of Mar. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on H U Group Holdings and its competitors.
Is H U Group Holdings' Notes Receivable too high?
H U Group Holdings' current Notes Receivable is 円0 Mil. Overall, H U Group Holdings has a GF Score™ of 67/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does H U Group Holdings' Notes Receivable compare to TMO and DHR?
H U Group Holdings' Notes Receivable of 円0 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Medical Diagnostics & Research company?
A good Notes Receivable depends on the Medical Diagnostics & Research industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on H U Group Holdings and its competitors. H U Group Holdings's current Notes Receivable is 円0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is H U Group Holdings stock overvalued right now?
Based on GuruFocus' analysis, H U Group Holdings (TSE:4544) is currently considered Modestly Overvalued. The stock's GF Value™ is 円2,774.67, compared to a current price of 円3,470.00 — trading 25.1% above its estimated fair value. The current Notes Receivable is 円0 Mil. H U Group Holdings' overall GF Score™ is 67/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For H U Group Holdings (TSE:4544), the current Notes Receivable is 円0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is H U Group Holdings (TSE:4544) Overvalued in 2026?

Based on GuruFocus' analysis, H U Group Holdings stock appears to be overvalued. The current stock price of 円3,470.00 is trading 25.1% above its estimated GF Value™ of 円2,774.67. GuruFocus considers H U Group Holdings to be Modestly Overvalued.

Key valuation signals for TSE:4544:

  • Notes Receivable: 円0 Mil
  • GF Value™: 円2,774.67 vs. price of 円3,470.00 (25.1% above fair value)
  • GF Score™: 67/100 with 5 warning signs

No single metric tells the full story. See the TSE:4544 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

H U Group Holdings Business Description

Other Exchanges MRCHF:USA
Address Shinjuku Mitsui Building, 2-1-1 Nishishinjuku, Shinjuku-ku, Tokyo, JPN, 163-0408
H U Group Holdings Inc operates in the healthcare field, focusing on clinical laboratory testing and reagents. The company is engaged in four main businesses. The Clinical Laboratory Testing Business receives samples taken from patients at medical institutions to test for the disease and confirm the condition of the patient's health; In Vitro Diagnostics develops, manufactures, and sells testing reagents and equipment inside and outside Japan; Sterilization & Related Services Business provides a range of medical-related services including sterilization; and Emerging New Business & Others is a new business for future growth.
67GF Score

Get the complete analysis for TSE:4544

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円3,470.00
Price
円2,774.67
GF Value